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Value of MR imaging in the differentiation
of benign and malignant orbital tumors
in adults
Abstract Purpose: To prospectively
evaluate magnetic resonance (MR)
imaging including dynamic contrast-
enhanced MR imaging in the differen-
tiationofbenignfrommalignantorbital
masses and to evaluate which MR
imaging features are most predictive of
malignant tumors. Materials and
methods: The study was approved by
the institutional review board and
signed informed consent was obtained.
Nonenhanced, static, and dynamic
contrast-enhanced MR imaging was
performed in 102 adult patients with an
orbital mass. Diagnosis was based on
histologic findings. MR imaging
featuresofbenignandmalignantorbital
lesions were evaluated correlated with
histological findings. Multivariate lo-
gistic regression analysis was em-
ployed to identify the best combination
of MR imaging features that might be
predictive of malignancy. Results:
Nonenhanced, static, and dynamic
enhancement MR imaging was signif-
icantly superior to two other models in
prediction of malignancy (p<0.05).
Multivariate logistic regression
analysis identified that the most dis-
criminating MR imaging features were
isointense mass on T2-weighted imag-
ing and a washout-type time–intensity
curveforbothobservers. Conclusion:
Nonenhanced, static, and dynamic
enhancement MR imaging improved
differentiation between benign and
malignant orbital masses in adult
patients.
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Introduction
Computed tomography (CT) and magnetic resonance (MR)
imaging are making an important impact on the character-
ization of orbital tumors and play an essential role in the
management of these tumors [1–8]. It is well known that
thoughtful analyses of CT and MR imaging of the orbit,
along with careful history, clinical examination, and
observation, are critical elements in the diagnosis and
differential diagnosis of orbital tumors. In general, bony
destruction of orbital wall on CTsuggests malignant tumor,
and hyperostosis underlies benign processes [1, 2, 8–11].
Tumors of the optic nerve sheath complex demonstrate
characteristic features on CTand MR imaging contributing
to the diagnosis and differential diagnosis [12–14].
Hyperintensity on T2-weighted imaging, and progressive
and total homogeneous filling up of an orbital mass on
dynamic contrast-enhanced MR imaging are considered as
a pathognomonic signof orbital cavernous hemangioma [1,
3, 6, 15–17]. Marked enlargement of the orbital mass after
compression of the neck on MR images is suggestive of
venous varix [1, 6, 16]. Orbital cyst is characterized by no
enhancement after contrast administration [4, 5, 8]. Orbital
invasion from adjacent structures such as the paranasal
sinus, globe, skull base, and nasopharynx shows soft tissue
mass extended from these regions, and can be readily
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by excisional biopsy [8, 18]. These features can facilitate
the differentiation of benign from malignant orbital soft
tissue masses. Thus, these lesions are not the focus of our
study.
However, the characterization of orbital lesions without
the above-mentioned characteristic imaging findings as
benign or malignant on the basis of CT and MR imaging
features remains a challenge. It is still difficult to differ-
entiate between benign and malignant diseases for these
patients. Dynamic contrast-enhanced (DCE) MR imaging,
a method that allows imaging of the physiology of the
microcirculation, has been applied to the study of tumors of
the breast, bone, bladder, prostate, head and neck, and other
regions [19–22]. DCE MR imaging has also been applied
to orbital tumors [17]. Nonetheless, little detailed informa-
tion about the sensitivity and specificity of MR imaging
including DCE MR imaging in the differentiation of benign
from malignant orbital tumors has been reported. Our
purpose was to prospectively evaluate static and DCE MR
imaging combined with nonenhanced MR imaging in the
differentiation of benign from malignant orbital masses that
were difficult to differentiate on CT or conventional MR
imaging, and to evaluate which MR imaging features are
most predictive of orbital malignant tumors with associated
interobserver variability.
Materials and methods
Patient population
Between June 2004 and February 2009, a total of 524 adult
patients with a suspicious orbital soft tissue mass on CT
were enrolled in the protocol, and MR imaging was
performed in 502 patients. Two patients did not undergo
MR imaging because of claustrophobia. Contrast-enhanced
MR imaging was not performed in 20 patients who
declined. Pathological data based on histological findings
in surgical specimens were available for 309 patients. Two
hundred and seven patients in line with exclusion criteria
comprised 26 patients who had a history of surgery or
treatment in the affected orbit, 6 patients whose images
were poor, 47 patients with orbital invasion by lesions of
adjacent structures such as the paranasal sinus, globe, skull
base, and nasopharynx, 12 patients with optic nerve
lesions, 23 patients who had orbital soft tissue masses
with significant bony destruction or hyperostosis or lesions
of the orbital wall on CT, 43 patients who showed
hyperintensity on T2-weighted imaging, and progressive
and total homogeneous filling up of an orbital mass on
dynamic gadolinium-enhanced MR imaging, 16 patients
with marked enlargement of the mass after compression of
the neck on MR images, and 34 patients with no
enhancement on contrast-enhanced MR imaging. Finally,
102 adult patients were eligible for participation.
Informed consent was obtained from all patients for
performance of radiological studies and analysis of clinical
data anonymously. Our institutional review board ap-
proved the study protocol.
MR imaging
MR imaging was performed on a General Electric (GE)
Signa 1.5-T MR imaging system (GE Healthcare, Mil-
waukee, WI) with an 8-channel head coil.
MR imaging was performed with T1-weighted (repeti-
tion time /echo time, 400/15 ms) and T2-weighted
(3,000/120) fast spin-echo images. A 16-cm field of
view, a 3-mm-thick section at 0 interval, and a 288×256
matrix with two signals acquired were used. DCE MR
imaging was performed by using a fast spoiled gradient
recalled (FSPGR) sequence with 8.4/4 ms, a flip angle of
15°, one excitation, a matrix of 256×160, a field of view of
220×220 mm, and a section thickness of 3.2 mm at 0
interval. A power injector (Medrad, Indianola, Pa) with an
injection flow rate of 2 mL/s was used. The acquisition of
the dynamic images began concurrently with the initiation
of the injection of 0.1 mmol of gadopentetate dimeglumine
(Magnevist, Schering, Berlin, Germany) per kilogram. The
contrast material injection was followed by a 20-mL saline
flush. In DCE MR imaging scanning, a total of 12 scans
were obtained. For each scan, 12 sections were obtained at
13 s. The interval between two scans was 12 s. Total
scanning time of DCE MR imaging was 288 s (4 min 48 s).
Image interpretation
DCE MR imaging was evaluated using a GE AW 4.2
workstation (GE Healthcare, Milwaukee, Wisconsin). A
region of interest (ROI) was drawn manually on the
dynamic images for assessment of the enhancement
kinetics. Observers were instructed to choose the area
that demonstrated the greatest degree of early enhancement
so that time–intensity curves (TICs) could be generated.
The ROI area was typically 8 mm
2. The contrast index (CI)
was calculated from the following equation: CI=[signal
intensity (post-contrast)−signal intensity (pre-contrast)]/
signal intensity (pre-contrast). Tpeak was the time to peak
enhancement. The TICs were analyzed qualitatively as
washout, persistent, or plateau-shaped curves.
Two experienced head and neck radiologists (15 years of
experience; 8 years of experience), blinded to the diagno-
sis, clinical history, and results of other imaging modalities,
independently evaluated MR imaging features on MR
imaging including DCE MR imaging. Each observer
evaluated MR imaging features and diagnosed the lesion
as benign or malignant with a five-point confidence rating
(1, definitely benign; 2, uncertain benign; 3, undetermined;
4, uncertain malignant; and 5, definitely malignant).
1693Observers were trained in MR image interpretation
before the investigation was initiated.
Statistical analysis
Univariate logistic regression models were fit for each
feature in an attempt to characterize the predictive ability of
each feature for identifying a malignant lesion.
The frequency distribution of individual MR imaging
features in the benign group was compared with that in the
malignant group by using chi-square tests. The Fisher
exact test was performed when the sample size in the
subgroups was deemed too small. A P value of less than
0.05 was considered to represent a significant difference.
Interobserver agreement of individual MR imaging
features was determined by means of κ analysis. A κ
value of less than 0.40 indicated poor agreement; that
equal to or greater than 0.40 and less than 0.60, moderate
agreement; that equal to or greater than 0.60 and less than
0.80, good agreement; and that equal to or greater than
0.80, excellent agreement.
Multivariate logistic regression analysis was employed
to identify the most important MR imaging features
predictive of orbital malignancy. Nonenhanced MR imag-
ing features (model 1), combination of nonenhanced and
static contrast-enhanced MR imaging features (model 2),
and DCE MR imaging in combination with nonenhanced
and static contrast-enhanced MR imaging features (model
3) were evaluated respectively. Final selection of multi-
variate predictors (model 4) was determined with stepwise
analysis as a backward-stepping procedure based on a
likelihood ratio test with a P value greater than 0.10 used
for exclusion from the model. The regression coefficient, b,
of the selected variables of model 4 provided an estimate of
the extent to which each MR imaging feature contributed to
the diagnostic accuracy. The Hosmer–Lemeshow good-
ness-of-fit test was used to assess model fit.
Results of subjective MR imaging diagnosis were
evaluated for sensitivity and specificity with a confidence
rating of uncertain benign, undetermined, uncertain malig-
nant, and definitely malignant as positive results requiring
histologic biopsy or surgery and with a confidence rating of
definitely benign as a negative result.
Data analysis was performed with statistical software
(SPSS for Windows, version 10.0; Chicago, Ill).
Results
Diagnosis
Orbital soft tissue masses were histologically confirmed in
all 102 patients (51 male and 51 female; mean age 50 years,
range 18–89 years). Benign lesions were demonstrated in
60 patients (22 male and 38 female; mean age 48 years,
range 20–76 years), and malignant lesions in 42 patients
(29 male and 13 female; mean age 52 years, range 18–
89 years). There was significant difference in the sex of
patients with benign versus malignant lesions (p=0.001).
There was no significant difference in the age of patients
with benign versus malignant lesions (p=0.205). The left
orbit was involved in 24 patients with benign lesions and in
22 patients with malignant lesions. The right orbit was
involved in 34 patients with benign lesions and in 16
patients with malignant lesions. Bilateral orbits were
involved in 2 patients with benign lesions and in 4 patients
with malignant lesions. There was no significant difference
in the side involving the mass between benign versus
malignant lesions (p=0.123).
Sixty benign lesions comprised 22 pleomorphic adeno-
mas of the lacrimal gland (21.6%), 16 schwannomas
(15.7%), 15 inflammatory pseudotumors (14.7%), 5
lymphangiomas (4.9%), and 2 solitary neurofibromas
(2%). Forty-two malignant lesions comprised 27 lympho-
mas (26.5%), 6 adenoid cystic carcinomas of the lacrimal
gland (5.9%), 5 adenocarcinomas of the lacrimal gland
(4.9%), 2 metastases (2%), 1 pleomorphic adenocarcinoma
of the lacrimal gland (1%), and 1 rhabdomyosarcoma (1%).
Frequency distribution of individual MR imaging
features and interobserver agreement between two
observers
Tables 1 and 2 describe the frequency distribution of
nonenhanced MR imaging features (Table 1) and static and
DCE MR imaging features (Table 2), correlation of these
features with pathological diagnosis (benign or malignant
tumors) for observer 1, as well as interobserver agreement
between observers 1 and 2. For both observers, there was
significant difference between the benign group and the
malignant group in the location, shape, and margin of the
mass, homogeneity on T1- and T2-weighted imaging,
signal intensity on T2-weighted imaging, pattern of
enhancement, and type of time–intensity curve (TIC) (P
<0.05) (Figs. 1, 2, 3,a n d4). For both observers, tumor
location including extraconal space and anterior orbit
preseptal space, irregular shape, ill-defined margin,
molding around orbital structures, a homogeneous mass
on T1- and T2-weighted imaging, isointensity relative to
extraocular muscle on T2-weighted imaging, homogene-
ous enhancement, and washout-type TIC were correlated
(P<0.05) with the diagnosis of malignancy (Figs. 1, 2,
and 3).
Tumor location, shape, margin, homogeneity on T1- and
T2-weighted imaging, signal intensity on T2-weighted
imaging, molding around orbital structures, globe inden-
tation caused by the tumor, pattern of enhancement, and
washout-type TIC had good to excellent interobserver
agreement. Other MR imaging features had moderate to
poor interobserver agreement.
1694Involvement of preseptal space, involvement of one
compartment, margin, molding around orbital structures,
an isointense mass relative to extraocular muscle on T1-and
T2-weightedimaging,ahomogeneousmassonT2-weighted
imaging,homogeneousenhancement,andwashout-typeTIC
had a high sensitivity and specificity for diagnosing malig-
nant versus benign processes (Table 3). Other MR imaging
features had a lower sensitivity or specificity (Table 3).
Table 1 Frequency distribution and correlation with final diagnosis of nonenhanced MR imaging parameters for observer 1 and
interobserver agreement
MR imaging feature Type of disease P value κ value
b
Overall Benign Malignant
N % N % N %
No. of patients 102 60 42
Tumor location
Intraconal 48 47 25 42 23 55 0.192 0.902
Extraconal 58 57 27 45 31 74 0.004 0.824
Lacrimal fossa 50 49 29 48 21 50 0.868 0.625
Anterior orbit preseptal 42 41 14 23 28 67 <0.001 0.647
No. of compartments involved <0.001 0.509
One compartment 46 45 38 63 8 19
Two compartments 26 25 12 20 14 33
Three compartments 19 19 7 12 12 29
Four compartments 11 11 3 5 8 19
No. of masses 0.026 0.496
Solitary 75 74 49 82 26 62
Multiple 27 26 11 18 16 38
Shape <0.001 0.802
Regular 42 41 34 57 8 19
Irregular 60 59 26 43 34 81
Margin <0.001 0.649
Well defined 62 61 48 80 14 33
Ill defined 40 39 12 20 28 67
Relationship between masses and adjacent structures
Molding structures 53 52 18 30 35 83 <0.001 0.727
Displacement 92 90 56 93 36 86 0.203 0.24
Globe indentation 25 25 18 30 7 17 0.123 0.678
Extraorbital involvement 21 21 9 15 12 29 0.095 0.468
T1 signal intensity
a 0.003 0.271
Hypointense 15 15 14 23 1 2
Isointense 87 85 46 77 41 98
Hyperintense 0 0 0 0 0 0
T1 homogeneity 0.018 0.622
Homogeneous 72 71 37 62 35 83
Inhomogeneous 30 29 23 38 7 17
T2 signal intensity
a <0.001 0.694
Hypointense 7 7 6 10 1 2
Isointense 56 55 21 35 35 84
Hyperintense 39 38 33 55 6 14
T2 homogeneity <0.001 0.624
Homogeneous 54 53 23 38 31 74
Inhomogeneous 48 47 37 62 11 26
aSignal intensity was compared with extraocular muscle
bA κ value (interobserver agreement) less than 0.40 represented poor agreement; that equal to or greater than 0.40 and less than 0.60, moderate
agreement; that equal to or greater than 0.60 and less than 0.80, good agreement; and that equal to or greater than 0.80, excellent agreement
1695Combination of orbital MR imaging features
Results of observers 1 and 2 are delineated in Table 4.
Logistic regression model 3, based on the combination of
nonenhanced, static, and dynamic contrast-enhanced MR
imaging features, hada higher ability to predict malignancy
than did logistic regression models 1 and 2 (p<0.05) with a
sensitivity of 83.3% and 83.3% and a specificity of 88.3%
and 91.7% for observers 1 and 2, respectively (Table 4).
Stepwise multivariate logistic regression analysis (model
4) with all evaluated MR imaging features revealed that
only two MR imaging features were significant predictors
of malignancy for observer 1 and three MR imaging
features were significant predictors of malignancy for
observer 2 (Table 4). The discriminating MR imaging
features between benign and malignant orbital masses of
observer 1 were isointense mass relative to extraocular
muscle on T2-weighted imaging (b=1.452, 95% con-
fidence interval 1.359–13.417) and a washout-type TIC
(b=1.452, 95% confidence interval 1.359–13.417). The
discriminating MR imaging features of observer 2 were
involvement of preseptal space (b=1.637, 95% confidence
interval 1.458–18.104), isointense mass relative to extra-
ocular muscle on T2-weighted imaging (b=1.512, 95%
confidence interval 1.379–14.930), and a washout-type
TIC (b=2.3, 95% confidence interval 3.034–32.081).
The Hosmer–Lemeshow goodness-of-fit test results
were not significantly different for each model and
indicated that all the models were adequately fitted.
Confidence of subjective MR imaging diagnosis
According to our five-point confidence rating scale of
uncertain benign, undetermined, uncertain malignant, or
definitely malignant as positive results requiring histolog-
ical biopsy or surgery and with a confidence rating of
definitely benign as a negative result, sensitivity of
nonenhanced MR imaging features was 81% (34/42) and
81% (34/42) and specificity was 58.3% (35/60) and 68.3%
(41/60) for observers 1 and 2, respectively. Sensitivity and
specificity of nonenhanced combined with static contrast-
Table 2 Frequency distribution and correlation with final diagnosis of static and dynamic contrast-enhanced MR imaging features for
observer 1 and interobserver agreement
MR imaging feature Type of disease P value κ value
a
Overall Benign Malignant
N % N % N %
No. of patients 102 60 42
Static enhancement
Pattern of enhancement <0.001 0.628
Homogeneous 49 48 20 33 29 69
Inhomogeneous 50 49 37 62 13 31
Peripheral 3 3 3 5 0 0
Dynamic enhancement
CI value 0.476 0.457
CI≤0.5 5 5 3 5 2 5
0.5<CI≤1 5 35 23 05 02 3 5 4
1<CI≤1.5 27 26 14 23 13 31
1.5<CI≤2 1 51 51 32 22 5
C I > 2 22002 5
Tpeak (ms) 0.200 0.576
T≤50 7 7 3 5 4 10
50<T≤75 90 88 53 88 37 88
75<T≤100 3 3 2 3 1 2
100<T≤125 2 2 2 3 0 0
T>125 0 0 0 0 0 0
TIC type <0.001
Persistent 28 27 28 47 0 0 0.535
Plateau-shaped 25 25 18 30 7 17 0.469
Washout 49 48 14 23 35 83 0.843
aA κ value (interobserver agreement) less than 0.40 represented poor agreement; that equal to or greater than 0.40 and less than 0.60,
moderate agreement; that equal to or greater than 0.60 and less than 0.80, good agreement; and that equal to or greater than 0.80, excellent
agreement
1696enhanced MR imaging features were the same as none-
nhanced MR imaging features for observers 1 and 2.
Sensitivity of nonenhanced combined with static and
dynamic contrast-enhanced MR imaging features was
97.6% (41/42) and 100% (42/42) and specificity was
71.7% (43/60) and 73.3% (44/60) for observers 1 and 2,
respectively, significantly higher than those of other two
models (p<0.05).
Discussion
Ben Simon et al. reported that none of the orbital imaging
features, including CT and MR imaging features, had a
high enough sensitivity to distinguish between malignant
and benign orbital tumors [8]. However, our study has
shown that some MR imaging features are associated with
a malignant disease and have good to excellent inter-
observer agreement between two observers. Of these
features, involvement of preseptal space, ill-defined mar-
gin, molding around orbital structures, isointensity on T2-
weighted imaging, a homogeneous mass on T2-weighted
imaging, homogeneous enhancement, and washout-type
TIC had a high sensitivity and specificity for diagnosing
malignant disease. Multivariate logistic regression analysis
revealed that the most predictive features for malignancy
were isointense mass on T2-weighted imaging and a
washout-type TIC for both observers.
Fig. 1 Transverse MR images in a 79-year-old man demonstrated a
well-circumscribed mass molding around the globe in the left
preseptal space (arrowhead) and extraconal space (arrow). a T1-
weighted image (400/15) showed a homogeneously isointense mass
relative to extraocular muscle. b T2-weighted image (3,000/120)
showed a homogeneously isointense mass relative to extraocular
muscle. c Static contrast-enhanced MR image (400/15) with fat
suppression showed mildly homogeneous enhancement of the mass.
d Time–intensity curve for this patient was characterized as a
washout curve. Pathologic examination revealed a non-Hodgkin’s
lymphoma
1697Orbital lymphoma, the most common primary orbital
malignancy in adults, usually manifests as a diffuse,
solid, enhancing mass with molding around the globe on
imaging studies, reflecting the irregular infiltration of
orbital structures [23–27]. Our results revealed that an
irregular mass was seen in all 27 patients with lympho-
ma, in which soft tissue mass was ill defined in 22
patients (81.5%) and well defined in only five patients
(18.5%). However, a circumscribed round or oblong
mass, seen in 48% to 54% of the patients with orbital
lymphoma on MRI or CT reported in the literature [25,
26], does not rule out orbital lymphoma. Our results and
recent literature [25, 26] indicated that orbital lymphoma
appeared to be isointense compared with extraocular
muscles on T1-weighted and T2-weighted images. This
was contrary to earlier studies that showed orbital
lymphoma appeared to be isointense compared with
extraocular muscles on T1-weighted images and hyper-
intense on T2-weighted imaging [27], but this may
explain one of the most predictive features for malig-
nancy—isointense mass on T2-weighted imaging.
Primary epithelial malignancies of the lacrimal gland are
the second most common malignant tumors in the orbit [23,
24]. Generally, a small circumscribed lesion in the lacrimal
gland is more likely to be benign and a larger or poorly
circumscribed tumor is more likely to be malignant on CT
or MR imaging [5, 10, 11, 28]. Erosion of bone can occur,
even when the primary epithelial malignant tumor is still
Fig. 2 Transverse MR images in a 30-year-old man identified an
oval well-defined mass (arrow) in the right lacrimal gland. a T1-
weighted image (400/15) showed a homogeneously isointense mass
relative to extraocular muscle. b T2-weighted image (3,000/120)
showed an inhomogeneously hyperintense mass relative to extraoc-
ular muscle. c Static contrast-enhanced MR image (400/15) with fat
suppression showed inhomogeneous enhancement of the mass. d
Time–intensity curve for this patient was characterized as a washout
curve. Pathologic examination revealed an adenoid cystic carcinoma
of the lacrimal gland
1698small [28]. However, primary epithelial malignancies of
the lacrimal gland may demonstrate a round or ovoid well-
defined soft tissue mass without bony erosion [28], which
was seen in four patients with adenoid cystic carcinoma of
the lacrimal gland in our study. For these patients, shape or
marginof the mass cannot be used to distinguish them from
benign disease, but three of these four patients with orbital
lymphoma showed washout-type TICs which were sug-
gestive of malignancy. Because bony destruction of orbital
wall depicted on CTsuggested malignant tumor, malignant
tumors of the lacrimal gland with bony destruction were
not included in our study.
In clinical practice, some malignant orbital tumors are
frequently misinterpreted as benign on nonenhanced MR
imaging or static enhanced MR imaging, perhaps because
of their small size, well-defined margins, and slow
progression [8]. However, these malignant orbital tumors
will demonstrate washout-type TICs on dynamic contrast-
enhanced MR imaging, which may help flag up benign-
appearinglesionsandallowlessexperiencedradiologists to
target lesions that need further work-up in a referral center.
Compared with the surface coil, the resolution of the 8-
channel head coil is limited. However, the orbital apex is
poorly demonstrated on images obtained with the surface
coil. Thus, we chose the 8-channel head coil rather than the
surface coil.
Limitations of this study included patient population
bias and the small sample size. Tumors included in the
Fig. 3 Transverse MR images in a 49-year-old man revealed an oval
well-defined mass (arrow) in right medial rectus muscle. a T1-
weighted image (400/15) showed a homogeneously isointense mass
relative to extraocular muscle. b T2-weighted image (3,000/120)
showed an inhomogeneously isointense mass relative to extraocular
muscle with patchy hyperintensity within the mass. c Static contrast-
enhanced MR image (400/15) with fat suppression showed inhomo-
geneous enhancement of the mass. d Time–intensity curve for this
patient was characterized as a washout curve. Pathologic examination
revealed a metastasis from lung adenocarcinoma
1699study reflect those that are more difficult to differentiate
benign from malignant by using imaging studies and the
referral pattern to our orbital clinic. Tumors that are easier
to distinguish benign from malignant by using imaging
studies are not included in our study, in which more benign
lesions were excluded. In addition, the analysis of dynamic
enhanced MR imaging was limited to qualitative analysis
and simple descriptive statistics and aimed to evaluate
predominant clinical practices. Advanced modeling will be
investigated in future work.
In conclusion, the most predictive features for malig-
nancy were isointense mass on T2-weighted imaging and
a washout-type TIC. In addition, location, shape, and
margin of the mass, molding around orbital structures,
and pattern of enhancement were critical features of
orbital masses that should be considered in lesion
characterization. The combination of nonenhanced, static,
and dynamic contrast-enhanced MR imaging was supe-
rior to combination of nonenhanced and static contrast-
enhanced MR imaging and nonenhanced MR imaging
alone in the differentiation of benign from malignant soft
tissue lesions in the orbit. The addition of dynamic
contrast-enhanced MR imaging substantially enhances
the accuracy of MR imaging in the differentiation of
benign from malignant orbital masses and facilitates
prediction of malignancy. Advances in the techniques of
MR imaging and the ability to interpret orbital MR
imaging will optimize the decision-making process in
treatment planning, determining the most efficient and
least invasive pathways toward helping our patients with
their disease. The multivariate models can serve an
important role as a training and decision support system
for assisting less experienced radiologists practicing
orbital MR imaging.
Fig. 4 Transverse MR images in a 45-year-old woman displayed an
oval well-defined mass (arrow) in right intraconal space. a T1-
weighted image (400/15) showed an inhomogeneously isointense
mass relative to extraocular muscle. b T2-weighted image
(3,000/120) showed an inhomogeneously hyperintense mass relative
to extraocular muscle. c Static contrast-enhanced MR image
(400/15) with fat suppression showed inhomogeneous enhancement
of the mass. d Time–intensity curve for this patient was
characterized as a persistent curve. Pathologic examination revealed
a schwannoma
1700Table 3 Positive predictive values, negative predictive values, sensitivity, and specificity of MR imaging features in evaluating malignant
versus benign diseases in patients with orbital soft tissue masses
Positive predictive value
a Negative predictive value
b Sensitivity
c Specificity
d
n % n % n % n %
No. of patients 42 60
Solitary mass 49 65.3 16 59.3 49 81.7 16 38.1
Extraconal involvement 31 53.4 33 75.0 31 73.8 33 55
Preseptal involvement 28 66.7 46 76.7 28 66.7 46 76.7
Shape 34 56.7 34 81.0 34 81.0 34 56.7
Margin 28 70.0 48 77.4 28 66.7 48 80.0
Molding structures 35 66.0 42 85.7 35 83.3 42 70.0
Inhomogeneous T1 37 51.4 7 23.3 37 61.7 7 16.7
Homogeneous T1 35 48.6 23 76.7 35 83.3 23 38.3
T1 hypointense 1 6.7 46 52.9 1 2.4 46 76.7
T1 isointense 41 47.1 14 93.3 41 97.6 46 76.7
Inhomogeneous T2 12 22.6 19 38.8 12 28.6 19 31.7
Homogeneous T2 30 61.2 41 77.4 30 71.4 41 68.3
T2 hypointense 1 14.3 54 56.8 1 2.4 54 90.0
T2 isointense 35 62.5 39 84.8 35 83.3 39 65.0
T2 hyperintense 6 15.4 27 42.9 6 14.3 27 45.0
Homogeneous enhancement 29 59.2 40 75.5 29 69.0 40 66.7
Inhomogeneous enhancement 13 26.0 23 44.2 13 31.0 23 38.3
Peripheral enhancement 0 0.0 57 57.6 0 0.0 57 95.0
Persistent-type TIC 28 100 42 56.8 28 46.7 42 100
Washout-type TIC 35 71.4 46 86.8 35 83.3 46 76.7
One compartment involved 33 60.0 38 80.9 33 78.6 38 63.3
Two compartments involved 20 66.7 50 69.4 20 47.6 50 83.3
Three compartments involved 8 72.7 57 62.6 8 19.5 57 95.0
Only features with significantly different occurrence between malignant and benign groups were included in the calculation
aRate of detecting disease among patients with positive test results equals number of patients with disease (malignant) and positive test
results per number of patients with positive test results
bRate of detecting nondisease among patients without positive test results equals number of patients without disease (malignant) and
negative test results per number of patients with negative results
cRate of positive test results among patients with disease equals number of patients with disease (malignant) and positive test results per
number of patients with disease (malignant)
dRate of negative test results among patients without disease equals number of patients without disease (malignant) and negative test results
per number of patients without disease (malignant)
Table 4 Logistic regression models of MR imaging parameters for observers 1 and 2: analysis of 102 patients with orbital soft tissue mass
Model No. of MR imaging
features
Sensitivity (n=42) Specificity (n=60)
Observer
1
Observer
2
Observer
1
Observer
2
Observer
1
Observer
2
1 Nonenhanced MR imaging features 21 21 78.6 (33)
a 76.2 (32) 86.7 (52) 83.3 (50)
2 Nonenhanced combined with static CE MR imaging features 23 23 78.6 (33) 73.8 (31) 88.3 (53) 86.7 (52)
3 Nonenhanced combined with static and DCE MR imaging
features
27 27 83.3 (35) 83.3 (35) 88.3 (53) 91.7 (55)
4 Stepwise logistic regression analysis of model 3 2
b 3
c 69.0 (29) 78.6 (33) 83.3 (50) 85.0 (51)
Differences between models 1 and 2, models 2 and 3, and models 1 and 3 were all significant (p<0.05) for observer 1. For observer 2,
differences between models 1 and 3, and models 2 and 3 were significant (p<0.05), but difference between models 1 and 2 was
insignificant (p>0.05)
aNumbers are percentages. Numbers in parentheses were used to calculate the percentages
bMR imaging features included isointensity on T2-weighted imaging and washout-type TIC
cMR imaging features included isointensity on T2-weighted imaging, washout-type TIC, and anterior orbit preseptal involvement
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